TY - JOUR
T1 - Heterozygous knockout of transforming growth factor-β1 protects dahl s rats against high salt-induced renal injury
AU - Roman, Richard J.
AU - Chen, Chun Cheng Andy
AU - Geurts, Aron M.
AU - Jacob, Howard J.
AU - Fan, Fan
PY - 2013/2/4
Y1 - 2013/2/4
N2 - Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury. Physiol Genomics 45: 110-118, 2013. First published December 18, 2012; doi:10.1152/physiolgenomics.00119.2012.-The present study employed a zinc-finger nuclease strategy to create heterozygous knockout (KO) rats for the transforming growth factor-β1 (Tgfb1) gene on the Dahl SS/Jr genetic background (TGF-β1+/- Dahl S). Intercrossing TGF-β1 +/- rats did not produce any homozygous KO rats (66.4% +/-, 33.6% +/+), indicating that the mutation is embryonic lethal. Six-week-old wild-type (WT) littermates and TGF-β1+/- Dahl S rats were fed a 0.4% (low salt, LS) or 8% NaCl (high salt, HS) diet for 5 wk. Renal cortical expression of TGF-β1, urinary TGF-β1 excretion, proteinuria, glomerular injury and tubulointerstitial fibrosis, and systolic blood pressure were similar in WT and TGF-β1+/- Dahl S rats maintained on the LS diet. The expression and urinary excretion of TGF-β1 increased to a greater extent in WT than in TGF-β1+/- Dahl S rats fed an HS diet for 1 wk. Systolic blood pressure rose by the same extent to 235 ± 2 mmHg in WT and 239 ± 4 mmHg in TGF-β1+/- Dahl S rats fed a HS diet for 5 wk. However, urinary protein excretion was significantly lower in TGF-β1+/- Dahl S than in the WT animals. The degree of glomerular injury and renal cortical and outer medullary fibrosis was markedly less in TGF-β1 +/- than in WT rats. These findings suggest that the loss of one copy of the TGF-β1 gene blunts the increase in renal TGF-β1 protein expression and slows the progression of proteinuria, glomerulosclerosis, and renal interstitial fibrosis in Dahl S rats fed an HS diet independently of changes in blood pressure.
AB - Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury. Physiol Genomics 45: 110-118, 2013. First published December 18, 2012; doi:10.1152/physiolgenomics.00119.2012.-The present study employed a zinc-finger nuclease strategy to create heterozygous knockout (KO) rats for the transforming growth factor-β1 (Tgfb1) gene on the Dahl SS/Jr genetic background (TGF-β1+/- Dahl S). Intercrossing TGF-β1 +/- rats did not produce any homozygous KO rats (66.4% +/-, 33.6% +/+), indicating that the mutation is embryonic lethal. Six-week-old wild-type (WT) littermates and TGF-β1+/- Dahl S rats were fed a 0.4% (low salt, LS) or 8% NaCl (high salt, HS) diet for 5 wk. Renal cortical expression of TGF-β1, urinary TGF-β1 excretion, proteinuria, glomerular injury and tubulointerstitial fibrosis, and systolic blood pressure were similar in WT and TGF-β1+/- Dahl S rats maintained on the LS diet. The expression and urinary excretion of TGF-β1 increased to a greater extent in WT than in TGF-β1+/- Dahl S rats fed an HS diet for 1 wk. Systolic blood pressure rose by the same extent to 235 ± 2 mmHg in WT and 239 ± 4 mmHg in TGF-β1+/- Dahl S rats fed a HS diet for 5 wk. However, urinary protein excretion was significantly lower in TGF-β1+/- Dahl S than in the WT animals. The degree of glomerular injury and renal cortical and outer medullary fibrosis was markedly less in TGF-β1 +/- than in WT rats. These findings suggest that the loss of one copy of the TGF-β1 gene blunts the increase in renal TGF-β1 protein expression and slows the progression of proteinuria, glomerulosclerosis, and renal interstitial fibrosis in Dahl S rats fed an HS diet independently of changes in blood pressure.
KW - Glomerular injury
KW - Hypertension
KW - Kidney disease
KW - Renal fibrosis
KW - Transforming growth factor beta 1
UR - http://www.scopus.com/inward/record.url?scp=84873418766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873418766&partnerID=8YFLogxK
U2 - 10.1152/physiolgenomics.00119.2012
DO - 10.1152/physiolgenomics.00119.2012
M3 - Article
C2 - 23249995
AN - SCOPUS:84873418766
SN - 1094-8341
VL - 45
SP - 110
EP - 118
JO - Physiological Genomics
JF - Physiological Genomics
IS - 3
ER -